after being listed on 682 per share level on NSE, tarsan share price soon got to the tune of 800 level. makes intraday highs of 807 on NSE. According to stock market experts, this stock is expected to move further due to strong fundamentals. The demand for the company’s products is expected to increase in the coming quarters, he added. He advises long term investors to keep counter to the target of 3 months 999 whereas for those applying for the listed benefits they advised to book the benefits as it is already paying more than the premium of around 20 per cent. 800 per share level.
Advising long term investors to hold Tarsons shares for the next 3 months; Ravi Singhal, Vice Chairman, GCL Securities said, “Demand for Tarson products is expected to move northwards and hence I would advise long term investors to counter the 3-month target. Maintaining a strict stop loss at 999 735 levels. However, for those who missed out on getting shares of Tarson Products during the allotment process, my advice is to wait till the market stabilizes as falling markets may bring down the Tarson shares at a discounted price.” For those who applied, Ravi Singhal advised them to book profit as they are already getting more than 20 per cent listing profit 800 per share level.
advising risk-averse investors to buy shares of Tarsons at current levels; Santosh Meena, Head of Research, Swastika Investmart Ltd., said, “Tarson Products Ltd. is backed by a strong management team with brand awareness and high quality goods. It is one of the leading life sciences suppliers in India. The company aims to Is planning loan fee and CAPEX after IPO, which will lead to further increase in revenue. We may see profit booking in the stock given global cues on concerns of new version of COVID-19. However, this is expected That we can see the demand for Tarson’s products in the coming quarters. Hence, long term investors can hold the stock while risk taking investors can buy the stock while maintaining the stop loss 590 levels.”
advising new buyers to wait for the trend reversal in the healthcare sector; Ravi Singh, Research Head and Vice President, ShareIndia, said, “Tarson manufactures a range of quality labware products that help advance scientific discovery and improve health systems. However, the healthcare sector is already at the bottom. So, it is advisable to book the position now and wait for the trend reversal across the sector.
Shares of Tarsan are listed on NSE today 682, about 3 percent higher than its upper price band 662 per share level. However, it soon rose and made its intraday high 807 on NSE, to get more than 20 per cent listing advantage to the lucky bidders who got the shares of Tarson through the allotment process.
Disclaimer: The views and recommendations given above are those of individual analysts or broking companies and not of Mint.
Never miss a story! Stay connected and informed with Mint.
download
Our App Now!!
,